Human study commenced

Human study commenced

Manchester, UK - 19 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, confirms that it has commenced its human study being carried out on its SkinBiotix® technology....

19th September, 2018 Read More

CEO Presentation

CEO Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening...

14th September, 2018 Read More

Shares and AJ Bell Investor Evening

Shares and AJ Bell Investor Evening

SkinBioTherapeutics will be attending and presenting at the Shares and AJ Bell evening event in Manchester on October 10 2018 at the Macdonald Manchester Hotel (nr Piccadilly Station). Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...

14th September, 2018 Read More

SkinBiotix® technology successful in stability testing

SkinBiotix® technology successful in stability testing

Manchester, UK - 03 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide an update to its announcement of 16 August 2018. The stability criteria required for its human study has been met and the Company e...

3rd September, 2018 Read More

Business update

Business update

Manchester, UK - 16 August 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide the following update:...

16th August, 2018 Read More

Shares and AJ Bell Investor Evening

Shares and AJ Bell Investor Evening

SkinBioTherapeutics to present on 12 September 2018 at the Shares and AJ Bell Spotlight Evening in Edinburgh. Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...

3rd August, 2018 Read More
investors logo